Unveiling the Role of Endoplasmic Reticulum Stress Pathways in Canine Demodicosis

Canine demodicosis is a prevalent skin disease caused by overpopulation of a commensal species of Demodex mite, yet its precise cause remains unknown. Research suggests that T cell exhaustion, increased immunosuppressive cytokines, induction of regulatory T cells, and increased expression of immune checkpoint inhibitors may contribute to its pathogenesis. This study aimed to gain a deeper understanding of the molecular changes occurring in canine demodicosis using mass spectrometry and pathway enrichment analysis. The results indicate that endoplasmic reticulum stress is promoting canine demodicosis through regulation of three linked signalling pathways: eIF2, mTOR, and eIF4 and p70S6K. These pathways are involved in the modulation of Toll-like receptors, most notably TLR2, and have been shown to play a role in the pathogenesis of skin diseases in both dogs and humans. Moreover, these pathways are also implicated in the promotion of immunosuppressive M2 phenotype macrophages. Immunohistochemical analysis, utilizing common markers of dendritic cells and macrophages, verified the presence of M2 macrophages in canine demodicosis. The proteomic analysis also identified immunological disease, organismal injury and abnormalities, and inflammatory response as the most significant underlying diseases and disorders associated with canine demodicosis. This study demonstrates that Demodex mites, through ER stress, unfolded protein response and M2 macrophages contribute to an immunosuppressive microenvironment thereby assisting in their proliferation.

[1]  T. LeRoith,et al.  Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies , 2023, Frontiers in Veterinary Science.

[2]  Enni Markkanen,et al.  Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue , 2022, Neoplasia.

[3]  R. Breathnach,et al.  A retrospective study of cases of canine demodicosis submitted to a commercial diagnostic laboratory servicing the United Kingdom and Ireland (2017-2018): Part 1 - Signalment, lesion distribution, treatments, and concurrent diseases. , 2022, Research in veterinary science.

[4]  Kun Huang,et al.  Proteomics as a tool to improve novel insights into skin diseases: what we know and where we should be going , 2022, Frontiers in Surgery.

[5]  Xiaolei Ding,et al.  The regulation of skin homeostasis, repair and the pathogenesis of skin diseases by spatiotemporal activation of epidermal mTOR signaling , 2022, Frontiers in Cell and Developmental Biology.

[6]  C. Freire-de-Lima,et al.  Immune Responses in Leishmaniasis: An Overview , 2022, Tropical medicine and infectious disease.

[7]  K. Izumi,et al.  Macrophage Polarity and Disease Control , 2021, International journal of molecular sciences.

[8]  Hongfu Xie,et al.  mTORC1-Mediated Angiogenesis is Required for the Development of Rosacea , 2021, Frontiers in Cell and Developmental Biology.

[9]  L. Skov,et al.  Towards Precision Dermatology: Emerging Role of Proteomic Analysis of the Skin , 2021, Dermatology.

[10]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity , 2021, Nature Reviews Immunology.

[11]  Martin Jones,et al.  The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function , 2020, bioRxiv.

[12]  Beth Walters,et al.  Translation Regulation by eIF2α Phosphorylation and mTORC1 Signaling Pathways in Non-Communicable Diseases (NCDs) , 2020, International journal of molecular sciences.

[13]  R. Foley,et al.  Demodex: a skin resident in man and his best friend , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[14]  Ping-Chih Ho,et al.  ER Stress Responses: An Emerging Modulator for Innate Immunity , 2020, Cells.

[15]  D. Dziedzic,et al.  CD163 and CCR7 as markers for macrophage polarization in lung cancer microenvironment , 2020, Central-European journal of immunology.

[16]  V. Sousa,et al.  Clinical and Immuno-Pathology Aspects of Canine Demodicosis , 2019 .

[17]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[18]  Kyeorda Kemp,et al.  Stressed: The Unfolded Protein Response in T Cell Development, Activation, and Function , 2019, International journal of molecular sciences.

[19]  M. McDermott,et al.  Tumour necrosis factor signalling in health and disease , 2019, F1000Research.

[20]  C. Buerger Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target , 2018, Front. Immunol..

[21]  W. Pavanelli,et al.  Macrophage Polarization in Leishmaniasis: Broadening Horizons , 2018, Front. Immunol..

[22]  J. Izdebska,et al.  The status of Demodex cornei: description of the species and developmental stages, and data on demodecid mites in the domestic dog Canis lupus familiaris , 2018, Medical and veterinary entomology.

[23]  S. Garg,et al.  Demodex canis targets TLRs to evade host immunity and induce canine demodicosis , 2018, Parasite immunology.

[24]  Jerome N Baron,et al.  Canine demodicosis: a retrospective study of a veterinary hospital population in California, USA (2000–2016) , 2018, Veterinary dermatology.

[25]  S. Garg,et al.  Demodex canis regulates cholinergic system mediated immunosuppressive pathways in canine demodicosis , 2017, Parasitology.

[26]  D. Sabatini,et al.  mTOR Signaling in Growth, Metabolism, and Disease , 2017, Cell.

[27]  Xiao-bin Cui,et al.  CD163 as a marker of M2 macrophage, contribute to predict aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma , 2017, Oncotarget.

[28]  Juan R. Cubillos-Ruiz,et al.  Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer , 2017, Cell.

[29]  M. Horton,et al.  mTORC2 signalling regulates M2 macrophage differentiation in response to helminth infection and adaptive thermogenesis , 2017, Nature Communications.

[30]  J. Cubillos-Ruiz,et al.  Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer , 2017, Journal of Immunotherapy for Cancer.

[31]  L. Partridge,et al.  mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation , 2016, Nature Communications.

[32]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[33]  M. Sozmen,et al.  Serum concentration and skin tissue expression of insulin-like growth factor 2 in canine generalized demodicosis. , 2015, Veterinary dermatology.

[34]  L. Gallego,et al.  Serum detection of IgG antibodies against Demodex canis by western blot in healthy dogs and dogs with juvenile generalized demodicosis. , 2015, Research in veterinary science.

[35]  B. Melnik Endoplasmic reticulum stress: key promoter of rosacea pathogenesis , 2014, Experimental dermatology.

[36]  L. Ferrer,et al.  Immunology and pathogenesis of canine demodicosis. , 2014, Veterinary dermatology.

[37]  Shanker K. Singh,et al.  The immuno-pathological conversions of canine demodicosis. , 2014, Veterinary parasitology.

[38]  Renu Malhotra,et al.  IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples , 2014, PloS one.

[39]  Andreas Krämer,et al.  Causal analysis approaches in Ingenuity Pathway Analysis , 2013, Bioinform..

[40]  S. Félix,et al.  Comparison of systemic interleukin 10 concentrations in healthy dogs and those suffering from recurring and first time Demodex canis infestations. , 2013, Veterinary parasitology.

[41]  Armand Sánchez,et al.  Phylogenetic relationships in three species of canine Demodex mite based on partial sequences of mitochondrial 16S rDNA. , 2012, Veterinary dermatology.

[42]  Scot R. Kimball,et al.  Role of p70S6K1-mediated Phosphorylation of eIF4B and PDCD4 Proteins in the Regulation of Protein Synthesis* , 2012, The Journal of Biological Chemistry.

[43]  R. Callejón,et al.  Molecular study on three morphotypes of Demodex mites (Acarina: Demodicidae) from dogs , 2012, Parasitology Research.

[44]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[45]  R. Mueller,et al.  Treatment of demodicosis in dogs: 2011 clinical practice guidelines. , 2012, Veterinary dermatology.

[46]  B. Sharma,et al.  The role of apoptosis in immunosuppression of dogs with demodicosis. , 2011, Veterinary immunology and immunopathology.

[47]  G. Chaudhuri,et al.  Leishmania-induced repression of selected non-coding RNA genes containing B-box element at their promoters in alternatively polarized M2 macrophages , 2011, Molecular and Cellular Biochemistry.

[48]  F. Heppner,et al.  M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis. , 2011, The American journal of pathology.

[49]  E. Lund,et al.  A case-control study of the risk factors for canine juvenile-onset generalized demodicosis in the USA. , 2011, Veterinary dermatology.

[50]  Daniel C. Liebler,et al.  Equivalence of Protein Inventories Obtained from Formalin-fixed Paraffin-embedded and Frozen Tissue in Multidimensional Liquid Chromatography-Tandem Mass Spectrometry Shotgun Proteomic Analysis* , 2009, Molecular & Cellular Proteomics.

[51]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[52]  K. Failing,et al.  MHC class II expression by follicular keratinocytes in canine demodicosis--an immunohistochemical study. , 2007, Veterinary immunology and immunopathology.

[53]  D. DeVoe,et al.  Proteome Analysis of Microdissected Formalin-fixed and Paraffin-embedded Tissue Specimens , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[54]  Brian L Hood,et al.  Proteomic Analysis of Formalin-fixed Prostate Cancer Tissue*S , 2005, Molecular & Cellular Proteomics.

[55]  M. Morimoto,et al.  Evaluation of cytokine messenger RNA expression in peripheral blood mononuclear cells from dogs with canine demodicosis. , 2002, The Journal of veterinary medical science.

[56]  Christine Brun,et al.  In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.

[57]  P. Moore,et al.  A Prospective Study of the Immunophenotype and Temporal Changes in the Histologic Lesions of Canine Demodicosis , 1997, Veterinary pathology.

[58]  M. Day An immunohistochemical study of the lesions of demodicosis in the dog. , 1997, Journal of comparative pathology.

[59]  D. Horohov,et al.  Evaluation of interleukin-2 production and interleukin-2 receptor expression in dogs with generalized demodicosis. , 1996, Veterinary dermatology.

[60]  R. Mueller,et al.  Diagnosis and treatment of demodicosis in dogs and cats , 2020 .

[61]  M. Okuda,et al.  The Journal of Veterinary Medical Science , 2015 .

[62]  T. Fukata,et al.  Significance of the CD4/CD8 lymphocytes ratio in dogs suffering from demodicosis , 2005 .

[63]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .